Insider · CIK 0002007050
Jurgi Camblong
chairofficerdirectorceo
Files at SOPH (SOPHiA GENETICS SA). First filing Mar 20, 2026, latest Oct 7, 2026.
In brief
Jurgi Camblong files SEC Form 4 as chair, director and CEO at SOPH (SOPHiA GENETICS SA). Since Mar 20, 2026, Jurgi Camblong has reported 0 open-market buys worth $0 and 19 open-market sells worth $2.7M, the latest filed on Oct 7, 2026.
A track record needs three past buys with six months of prices behind them; Jurgi Camblong has 0, so none is measured yet.
The newest scored trade: sold $327k of SOPH on Oct 5, 2026, filed Oct 7, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 19 sells worth $2.7M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 19
$0 bought, $2.7M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SOPH: SOPHiA GENETICS SA
SOPHOct 12, 2026 · close 7.22
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | SOPHiA GENETICS SA | $327k 40,172 shares | -1% | +111% from low-8% from high | |
| 23Weak | SOPHiA GENETICS SA | $65k 8,500 shares | -0% | +144% from low-15% from high | |
| 27Weak | SOPHiA GENETICS SA | $209k 28,500 shares | -1% | +156% from low0% from high | |
| 26Weak | SOPHiA GENETICS SA | $138k 20,000 shares | -1% | +127% from low0% from high | |
| 14Weak | SOPHiA GENETICS SA | $286k 44,381 shares | -1% | +110% from low0% from high | |
| 22Weak | SOPHiA GENETICS SA | $48k 8,500 shares | -0% | +88% from low-6% from high | |
| 25Weak | SOPHiA GENETICS SA | $93k 17,685 shares | -0% | +81% from low-9% from high | |
| 25Weak | SOPHiA GENETICS SA | $118k 22,486 shares | -1% | +77% from low-11% from high | |
| 18Weak | SOPHiA GENETICS SA | $507k 83,679 shares | -2% | +100% from low0% from high | |
| 19Weak | SOPHiA GENETICS SA | $298k 51,442 shares | -1% | +90% from low0% from high | |
| 26Weak | SOPHiA GENETICS SA | $45k 8,500 shares | -0% | +82% from low-5% from high | |
| 20Weak | SOPHiA GENETICS SA | $21k 4,486 shares | -0% | +64% from low-15% from high | |
| 26Weak | SOPHiA GENETICS SA | $43k 8,500 shares | -0% | +68% from low-13% from high | |
| 20Weak | SOPHiA GENETICS SA | $23k 4,486 shares | -0% | +87% from low-6% from high | |
| 34Weak | SOPHiA GENETICS SA | $301k 60,602 shares | -2% | +78% from low-10% from high | |
| 29Weak | SOPHiA GENETICS SA | $79k 16,631 shares | -0% | +69% from low-15% from high | |
| 20Weak | SOPHiA GENETICS SA | $23k 4,750 shares | -0% | +83% from low-12% from high | |
| 20Weak | SOPHiA GENETICS SA | $25k 5,100 shares | -0% | +86% from low-10% from high | |
| 20Weak | SOPHiA GENETICS SA | $21k 4,486 shares | -0% | +83% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHIA GENETICS SA | 65,672 0.08% of outstanding | $530k | Oct 5, 2026 | $958k |
| Aug 7, 2026 | SOPH SOPHIA GENETICS SA | 20,000 0.02% of outstanding | $134k | Aug 7, 2026 | $1.6M |
| Aug 4, 2026 | SOPH SOPHIA GENETICS SA | 20,000 0.02% of outstanding | $114k | Aug 4, 2026 | $1.5M |
| Jul 21, 2026 | SOPH SOPHIA GENETICS SA | 37,000 0.05% of outstanding | $234k | Jul 21, 2026 | $1.3M |
| Jul 20, 2026 | SOPH SOPHIA GENETICS SA | 24,381 0.03% of outstanding | $143k | Jul 20, 2026 | $1.2M |
| Jul 7, 2026 | SOPH SOPHIA GENETICS SA | 24,290 0.03% of outstanding | $130k | Jul 7, 2026 | $1.5M |
| Jun 30, 2026 | SOPH SOPHIA GENETICS SA | 70,000 0.10% of outstanding | $419k | Jun 30, 2026 | $965k |
| Jun 29, 2026 | SOPH SOPHIA GENETICS SA | 20,000 0.03% of outstanding | $115k | Jun 29, 2026 | $857k |
| Jun 26, 2026 | SOPH SOPHIA GENETICS SA | 68,129 0.09% of outstanding | $388k | Jun 26, 2026 | $567k |
| Jun 25, 2026 | SOPH SOPHIA GENETICS SA | 1,373 0.00% of outstanding | $7,579 | Jun 25, 2026 | $559k |
| May 19, 2026 | SOPH SOPHIA GENETICS SA | 12,986 0.02% of outstanding | $61k | May 19, 2026 | $556k |
| Apr 20, 2026 | SOPH SOPHIA GENETICS SA | 12,986 0.02% of outstanding | $69k | Apr 20, 2026 | $763k |
| Apr 6, 2026 | SOPH SOPHIA GENETICS SA | 87,083 0.13% of outstanding | $439k | Apr 6, 2026 | $1.4M |
| Mar 19, 2026 | SOPH SOPHIA GENETICS SA | 4,486 0.01% of outstanding | $22k | Mar 19, 2026 | $1.7M |
| Mar 16, 2026 | SOPH SOPHIA GENETICS SA | 1,984 0.00% of outstanding | $9,146 | Mar 16, 2026 | $1.6M |
| Jan 22, 2026 | SOPH SOPHIA GENETICS SA | 57,001 0.08% of outstanding | $309k | Jan 22, 2026 | $1.6M |
| Jan 20, 2026 | SOPH SOPHIA GENETICS SA | 7,485 0.01% of outstanding | $41k | Jan 20, 2026 | $1.5M |
| Jan 16, 2026 | SOPH SOPHIA GENETICS SA | 30,959 0.05% of outstanding | $160k | Jan 16, 2026 | $1.3M |
| Jan 9, 2026 | SOPH SOPHIA GENETICS SA | 117,541 0.17% of outstanding | $583k | Jan 9, 2026 | $849k |
| Jan 7, 2026 | SOPH SOPHIA GENETICS SA | 30,000 0.04% of outstanding | $144k | Jan 7, 2026 | $586k |
| Jan 2, 2026 | SOPH SOPHIA GENETICS SA | 46,886 0.07% of outstanding | $219k | Jan 2, 2026 | $588k |
| Dec 31, 2025 | SOPH SOPHIA GENETICS SA | 482 0.00% of outstanding | $2,280 | Dec 31, 2025 | $524k |
| Dec 29, 2025 | SOPH SOPHIA GENETICS SA | 30,000 0.04% of outstanding | $142k | Dec 29, 2025 | $444k |
| Dec 10, 2025 | SOPH SOPHIA GENETICS SA | 6,412 0.01% of outstanding | $29k | Dec 10, 2025 | $638k |
| Nov 10, 2025 | SOPH SOPHIA GENETICS SA | 24,641 0.04% of outstanding | $108k | Nov 10, 2025 | $707k |
Transactions
Every row this insider has filed, 45 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -40,172 | $8.13 | $327k | 3,395,650 | 8 d ago |
| Sep 10, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -8,500 | $7.66 | $65k | 3,435,822 | 31 d ago |
| Aug 7, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -20,000 | $7.23 | $145k | 3,452,822 | Aug 10, 2026 |
| Aug 10, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -8,500 | $7.61 | $65k | 3,444,322 | Aug 10, 2026 |
| Aug 4, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -20,000 | $6.92 | $138k | 3,472,822 | Aug 5, 2026 |
| Jul 20, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -19,800 | $6.32 | $125k | 3,512,822 | Jul 22, 2026 |
| Jul 20, 2026 | SOPH SOPHiA GENETICS SA | MOption exercise Ordinary Shares10b5-1 | +4,581 | $3.16 | $14k | 3,517,403 | Jul 22, 2026 |
| Jul 20, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -4,581 | $6.17 | $28k | 3,512,822 | Jul 22, 2026 |
| Jul 21, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -20,000 | $6.63 | $133k | 3,492,822 | Jul 22, 2026 |
| Jul 20, 2026 | SOPH SOPHiA GENETICS SA | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -4,581 | $0.00 | $0 | 0 | Jul 22, 2026 |
| Jul 10, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -8,500 | $5.62 | $48k | 3,532,622 | Jul 14, 2026 |
| Jul 7, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -17,685 | $5.28 | $93k | 3,541,122 | Jul 8, 2026 |
| Jul 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -22,486 | $5.26 | $118k | 3,558,807 | Jul 7, 2026 |
| Jun 29, 2026 | SOPH SOPHiA GENETICS SA | MOption exercise Ordinary Shares10b5-1 | +18,060 | $3.16 | $57k | 3,619,553 | Jul 1, 2026 |
| Jun 29, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -18,060 | $5.87 | $106k | 3,601,493 | Jul 1, 2026 |
| Jun 29, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -350 | $6.00 | $2,100 | 3,601,143 | Jul 1, 2026 |
| Jun 30, 2026 | SOPH SOPHiA GENETICS SA | MOption exercise Ordinary Shares10b5-1 | +45,419 | $3.16 | $144k | 3,646,562 | Jul 1, 2026 |
| Jun 30, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -45,419 | $6.14 | $279k | 3,601,143 | Jul 1, 2026 |
| Jun 30, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -19,650 | $6.02 | $118k | 3,581,493 | Jul 1, 2026 |
| Jun 30, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -200 | $6.30 | $1,260 | 3,581,293 | Jul 1, 2026 |
| Jun 29, 2026 | SOPH SOPHiA GENETICS SA | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -18,060 | $0.00 | $0 | 50,000 | Jul 1, 2026 |
| Jun 30, 2026 | SOPH SOPHiA GENETICS SA | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -45,419 | $0.00 | $0 | 4,581 | Jul 1, 2026 |
| Jun 25, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,373 | $5.70 | $7,826 | 3,619,622 | Jun 29, 2026 |
| Jun 26, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -18,129 | $5.73 | $104k | 3,601,493 | Jun 29, 2026 |
| Jun 26, 2026 | SOPH SOPHiA GENETICS SA | MOption exercise Ordinary Shares10b5-1 | +31,940 | $3.16 | $101k | 3,633,433 | Jun 29, 2026 |
| Jun 26, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -31,940 | $5.84 | $186k | 3,601,493 | Jun 29, 2026 |
| Jun 26, 2026 | SOPH SOPHiA GENETICS SA | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -31,940 | $0.00 | $0 | 68,060 | Jun 29, 2026 |
| Jun 10, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -8,500 | $5.24 | $45k | 3,620,995 | Jun 11, 2026 |
| May 19, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -4,486 | $4.60 | $21k | 3,629,495 | May 20, 2026 |
| May 11, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -8,500 | $5.09 | $43k | 3,633,981 | May 12, 2026 |
| Apr 20, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -4,486 | $5.21 | $23k | 3,642,481 | Apr 21, 2026 |
| Apr 14, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -43,129 | $4.96 | $214k | 3,664,440 | Apr 16, 2026 |
| Apr 15, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -17,473 | $5.00 | $87k | 3,646,967 | Apr 16, 2026 |
| Apr 10, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -8,500 | $4.72 | $40k | 3,715,700 | Apr 14, 2026 |
| Apr 10, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -3,732 | $4.72 | $18k | 3,711,968 | Apr 14, 2026 |
| Apr 13, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -4,399 | $4.76 | $21k | 3,707,569 | Apr 14, 2026 |
| Apr 8, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,800 | $4.84 | $14k | 3,726,150 | Apr 10, 2026 |
| Apr 9, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,950 | $4.74 | $9,244 | 3,724,200 | Apr 10, 2026 |
| Apr 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,600 | $4.85 | $13k | 3,731,450 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +431,211 | $0.00 | $0 | 3,734,050 | Apr 8, 2026 |
| Apr 7, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,500 | $4.86 | $12k | 3,728,950 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +628,743 | $0.00 | $0 | 628,743 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +431,211 | $0.00 | $0 | 431,211 | Apr 3, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +628,743 | $0.00 | $0 | 628,743 | Apr 3, 2026 |
| Mar 19, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -4,486 | $4.77 | $21k | 3,302,839 | Mar 20, 2026 |
Questions about Jurgi Camblong
Answered from the filings on this page, as of the latest one.
Is Jurgi Camblong buying or selling?
In the last 12 months Jurgi Camblong reported 0 open-market buys worth $0 and 19 open-market sells worth $2.7M on SEC Form 4; the latest was sold $327k of SOPH on Oct 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Jurgi Camblong's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jurgi Camblong has 0.
Where does Jurgi Camblong file Form 4?
Jurgi Camblong has filed Form 4 at SOPH (SOPHiA GENETICS SA) as Executive Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.